Cephalomannine

CAS# 71610-00-9

Cephalomannine

Catalog No. BCN5343----Order now to get a substantial discount!

Product Name & Size Price Stock
Cephalomannine: 5mg $35 In Stock
Cephalomannine: 10mg Please Inquire In Stock
Cephalomannine: 20mg Please Inquire Please Inquire
Cephalomannine: 50mg Please Inquire Please Inquire
Cephalomannine: 100mg Please Inquire Please Inquire
Cephalomannine: 200mg Please Inquire Please Inquire
Cephalomannine: 500mg Please Inquire Please Inquire
Cephalomannine: 1000mg Please Inquire Please Inquire

Quality Control of Cephalomannine

Number of papers citing our products

Chemical structure

Cephalomannine

3D structure

Chemical Properties of Cephalomannine

Cas No. 71610-00-9 SDF Download SDF
PubChem ID 5281819 Appearance White powder
Formula C45H53NO14 M.Wt 831.91
Type of Compound Diterpenoids Storage Desiccate at -20°C
Solubility Soluble to 100 mg/mL (120.2 mM) in DMSO
SMILES CC=C(C)C(=O)NC(C1=CC=CC=C1)C(C(=O)OC2CC3(C(C4C(C(CC5C4(CO5)OC(=O)C)O)(C(=O)C(C(=C2C)C3(C)C)OC(=O)C)C)OC(=O)C6=CC=CC=C6)O)O
Standard InChIKey DBXFAPJCZABTDR-UJLUYDJNSA-N
Standard InChI InChI=1S/C45H53NO14/c1-9-23(2)39(52)46-33(27-16-12-10-13-17-27)34(50)41(54)58-29-21-45(55)38(59-40(53)28-18-14-11-15-19-28)36-43(8,30(49)20-31-44(36,22-56-31)60-26(5)48)37(51)35(57-25(4)47)32(24(29)3)42(45,6)7/h9-19,29-31,33-36,38,49-50,55H,20-22H2,1-8H3,(H,46,52)/b23-9+/t29-,30-,31+,33-,34+,35+,36?,38-,43+,44-,45+/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Cephalomannine

The barks of Cephalotaxus sinensis (Rehd. et Wils.) Li

Biological Activity of Cephalomannine

DescriptionCephalomannine is a taxol derivative with antitumor, antiproliferative properties, it shows cytotoxicity in human glial and neuroblastoma cell-lines.
TargetsP450 (e.g. CYP17)
In vitro

Cephalomannine and 10-deacetyltaxol cytotoxicity in human glial and neuroblastoma cell-lines.[Pubmed: 21573554]

Int J Oncol. 1993 Feb;2(2):297-9.


METHODS AND RESULTS:
The cytotoxic effects of taxol, 10-deacetyltaxol, and Cephalomannine at concentrations of 0.1 mug/ml to 10.0 mug/ml for one and 24 hours exposure were determined in two human glioblastoma multiforme and two neuroblastoma cell lines using the MTT method. The neuroblastoma cell lines were established from previously treated patients, while the glioblastomas were from untreated patients. There was a proportionate concentration-toxicity relationship for all four cell lines. The neuroblastoma SK-N-FI was consistently the most resistant to all three drugs. The order of potency after a one hour exposure was taxol, 10-deacetyltaxol and Cephalomannine. Cephalomannine contained 1.5% taxol impurity and 10-deacetyltaxol, 4.5% taxol hence the contribution of taxol to these substances' toxic effects was minimal.
CONCLUSIONS:
We conclude that tumors of the central and peripheral nervous system are sensitive to 10-deacetyltaxol and Cephalomannine and these drugs are less toxic than taxol but remain within a therapeutic range.

Protocol of Cephalomannine

Structure Identification
Fitoterapia. 2013 Oct;90:79-84.

Synthesis, isolation, stereostructure and cytotoxicity of paclitaxel analogs from cephalomannine.[Pubmed: 23876369]

Four paclitaxel derivatives were afforded by preparative HPLC separation of two pairs of diastereoisomers, which were obtained by catalytic hydrogenation and epoxidation of the C-13 side-chain double bond of Cephalomannine, a naturally occurring paclitaxel analog.
METHODS AND RESULTS:
The four paclitaxel derivatives were analyzed using NMR, CD spectroscopy, and side-chain hydrolysis in order to measure their optical rotations and GC characteristics. In this way, the stereoconfigurations of the products were determined. Evaluation of the compounds' activity indicated that they had differing cytotoxic activities: compound 5 had superior activity in BCG-823 tumor cells compared to paclitaxel, while compound 7 had superior activity in HCT-8 and A549 tumor cells compared to paclitaxel.
CONCLUSIONS:
These results indicate that the stereoconfiguration of the paclitaxel N-acyl side chain has a significant impact on its activity.

Drug Metab Dispos. 2008 Feb;36(2):418-26.

Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel.[Pubmed: 18039807]

To investigate how taxane's substituents at C3' affect its metabolism, we compared the metabolism of Cephalomannine and paclitaxel, a pair of analogs that differ slightly at the C3' position.
METHODS AND RESULTS:
After Cephalomannine was incubated with human liver microsomes in an NADPH-generating system, two monohydroxylated metabolites (M1 and M2) were detected by liquid chromatography/tandem mass spectrometry. C4'' (M1) and C6alpha (M2) were proposed as the possible hydroxylation sites, and the structure of M1 was confirmed by (1)H NMR. Chemical inhibition studies and assays with recombinant human cytochromes P450 (P450s) indicated that 4''-hydroxyCephalomannine was generated predominantly by CYP3A4 and 6alpha-hydroxyCephalomannine by CYP2C8. The overall biotransformation rate between paclitaxel and Cephalomannine differed slightly (184 vs. 145 pmol/min/mg), but the average ratio of metabolites hydroxylated at the C13 side chain to C6alpha for paclitaxel and Cephalomannine varied significantly (15:85 vs. 64:36) in five human liver samples. Compared with paclitaxel, the major hydroxylation site transferred from C6alpha to C4'', and the main metabolizing P450 changed from CYP2C8 to CYP3A4 for Cephalomannine. In the incubation system with rat or minipig liver microsomes, only 4''-hydroxyCephalomannine was detected, and its formation was inhibited by CYP3A inhibitors. Molecular docking by AutoDock suggested that Cephalomannine adopted an orientation in favor of 4''-hydroxylation, whereas paclitaxel adopted an orientation favoring 3'-p-hydroxylation. Kinetic studies showed that CYP3A4 catalyzed Cephalomannine more efficiently than paclitaxel due to an increased V(m).
CONCLUSIONS:
Our results demonstrate that relatively minor modification of taxane at C3' has major consequence on the metabolism.

Cephalomannine Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Cephalomannine Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Cephalomannine

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.2021 mL 6.0103 mL 12.0205 mL 24.0411 mL 30.0513 mL
5 mM 0.2404 mL 1.2021 mL 2.4041 mL 4.8082 mL 6.0103 mL
10 mM 0.1202 mL 0.601 mL 1.2021 mL 2.4041 mL 3.0051 mL
50 mM 0.024 mL 0.1202 mL 0.2404 mL 0.4808 mL 0.601 mL
100 mM 0.012 mL 0.0601 mL 0.1202 mL 0.2404 mL 0.3005 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Cephalomannine

Cephalomannine is a taxol derivative with antitumor, antiproliferative properties. IC50 value: Target: Cephalomannine is an active anti-cancer agent obtained from Taxus yunnanensis and has an antineoplastic effect on tumors found in mice. Cephalomannine is a chemotherapy drug that is given as a treatment for some types of cancer. Cephalomannine is most commonly used to treat non-small cell lung cancer.

References:
[1]. T. Grobosch, B. Schwarze, D. Stoecklein et al. Fatal poisoning with Taxus baccata. Quantification of Paclitaxel (taxol A), 10-Deacetyltaxol, Baccatin III, 10-Deacetylbaccatin III, Cephalomannine (taxol B), and 3,5-Dimethoxyphenol in Body Fluids by Liquid [2]. Jing Zhang et al., Simultaneous Determination of 10-Deacetylbaccatin,Cephalomannine and Taxol in Different Parts of Taxus Media with Different Growth Years by UPLC. Applied Mechanics and Materials. 2011, 108, 326. [3]. Chang Z, Guo N, Liu T, et al. Distribution and variation of paclitaxel and cephalomannine contents in wild Taxus cuspidata. Zhongguo Zhong Yao Za Zhi. 2011 Feb;36(3):294-8. [4]. R Matesanz, J Rodríguez-Salarichs, B Pera, et al. Modulation of Microtubule Interprotofilament Interactions by Modified Taxanes. Biophysical Journal, 2011,101(12): 2970-2980. [5]. Elena Riva, Martin Mattarella, Stella Borrelli, et al. Preparation of Fluorescent Tubulin Binders. ChemPlusChem. Early View (Online Version of Record published before inclusion in an issue)

Featured Products
New Products
 

References on Cephalomannine

Cephalomannine and 10-deacetyltaxol cytotoxicity in human glial and neuroblastoma cell-lines.[Pubmed:21573554]

Int J Oncol. 1993 Feb;2(2):297-9.

The cytotoxic effects of taxol, 10-deacetyltaxol, and Cephalomannine at concentrations of 0.1 mug/ml to 10.0 mug/ml for one and 24 hours exposure were determined in two human glioblastoma multiforme and two neuroblastoma cell lines using the MTT method. The neuroblastoma cell lines were established from previously treated patients, while the glioblastomas were from untreated patients. There was a proportionate concentration-toxicity relationship for all four cell lines. The neuroblastoma SK-N-FI was consistently the most resistant to all three drugs. The order of potency after a one hour exposure was taxol, 10-deacetyltaxol and Cephalomannine. Cephalomannine contained 1.5% taxol impurity and 10-deacetyltaxol, 4.5% taxol hence the contribution of taxol to these substances' toxic effects was minimal. We conclude that tumors of the central and peripheral nervous system are sensitive to 10-deacetyltaxol and Cephalomannine and these drugs are less toxic than taxol but remain within a therapeutic range.

Synthesis, isolation, stereostructure and cytotoxicity of paclitaxel analogs from cephalomannine.[Pubmed:23876369]

Fitoterapia. 2013 Oct;90:79-84.

Four paclitaxel derivatives were afforded by preparative HPLC separation of two pairs of diastereoisomers, which were obtained by catalytic hydrogenation and epoxidation of the C-13 side-chain double bond of Cephalomannine, a naturally occurring paclitaxel analog. The four paclitaxel derivatives were analyzed using NMR, CD spectroscopy, and side-chain hydrolysis in order to measure their optical rotations and GC characteristics. In this way, the stereoconfigurations of the products were determined. Evaluation of the compounds' activity indicated that they had differing cytotoxic activities: compound 5 had superior activity in BCG-823 tumor cells compared to paclitaxel, while compound 7 had superior activity in HCT-8 and A549 tumor cells compared to paclitaxel. These results indicate that the stereoconfiguration of the paclitaxel N-acyl side chain has a significant impact on its activity.

Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel.[Pubmed:18039807]

Drug Metab Dispos. 2008 Feb;36(2):418-26.

To investigate how taxane's substituents at C3' affect its metabolism, we compared the metabolism of Cephalomannine and paclitaxel, a pair of analogs that differ slightly at the C3' position. After Cephalomannine was incubated with human liver microsomes in an NADPH-generating system, two monohydroxylated metabolites (M1 and M2) were detected by liquid chromatography/tandem mass spectrometry. C4'' (M1) and C6alpha (M2) were proposed as the possible hydroxylation sites, and the structure of M1 was confirmed by (1)H NMR. Chemical inhibition studies and assays with recombinant human cytochromes P450 (P450s) indicated that 4''-hydroxyCephalomannine was generated predominantly by CYP3A4 and 6alpha-hydroxyCephalomannine by CYP2C8. The overall biotransformation rate between paclitaxel and Cephalomannine differed slightly (184 vs. 145 pmol/min/mg), but the average ratio of metabolites hydroxylated at the C13 side chain to C6alpha for paclitaxel and Cephalomannine varied significantly (15:85 vs. 64:36) in five human liver samples. Compared with paclitaxel, the major hydroxylation site transferred from C6alpha to C4'', and the main metabolizing P450 changed from CYP2C8 to CYP3A4 for Cephalomannine. In the incubation system with rat or minipig liver microsomes, only 4''-hydroxyCephalomannine was detected, and its formation was inhibited by CYP3A inhibitors. Molecular docking by AutoDock suggested that Cephalomannine adopted an orientation in favor of 4''-hydroxylation, whereas paclitaxel adopted an orientation favoring 3'-p-hydroxylation. Kinetic studies showed that CYP3A4 catalyzed Cephalomannine more efficiently than paclitaxel due to an increased V(m). Our results demonstrate that relatively minor modification of taxane at C3' has major consequence on the metabolism.

Description

Cephalomannine is an active anti-cancer agent obtained from Taxus yunnanensis and has an antineoplastic effect on tumors found in mice.

Keywords:

Cephalomannine,71610-00-9,Natural Products, buy Cephalomannine , Cephalomannine supplier , purchase Cephalomannine , Cephalomannine cost , Cephalomannine manufacturer , order Cephalomannine , high purity Cephalomannine

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: